News

ADXS-HPV is Advaxis’ lead immunotherapy drug candidate designed to target cells expressing the HPV gene E7. Expression of the E7 gene from high-risk HPV variants is responsible for

According to Allergan, the Irish Medicines Board’s positive opinion an important step towards securing national licenses in the 14 European countries involved in the MRP and marks a

Grupo Ferrer Internacional (Ferrer) is commercializing ADASUVE in the Nordic countries via a distribution agreement with Medivir. Ferrer is Alexza’s commercial partner for ADASUVE in the Europe, Latin

It is indicated for the treatment of excess visceral adipose tissue, as evaluated by waist circumference = 95 cm for men and = 94 cm for women, and

MEDIWIET is a Dutch organization of patients using medicinal cannabis based medication. Main aim of the trial is to further advance the knowledge of cannabis plant based product

The award supports preclinical studies to confirm that Oricula’s new chemical entities are both safe and effective for hearing protection. When complete, the results will form the basis

Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic. According to the company, Incruse contains 62.5mcg umeclidinium and is delivered

The collaboration aligns the research efforts of both firms around projects which are designed to develop a deep understanding of the pathogenesis and progression of MS and to

Medpace Laboratories, Singapore will serve and support new and existing Medpace pharmaceutical clients conducting clinical research in the rapidly expanding Asia Pacific region. With dedicated project management and